Ilsung Pharm (003120) - Total Liabilities

Latest as of December 2025: ₩16.67 Billion KRW ≈ $11.29 Million USD

Based on the latest financial reports, Ilsung Pharm (003120) has total liabilities worth ₩16.67 Billion KRW (≈ $11.29 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Ilsung Pharm growing its equity to track the company's year-over-year net asset growth rate.

Ilsung Pharm - Total Liabilities Trend (2013–2025)

This chart illustrates how Ilsung Pharm's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Ilsung Pharm to measure how efficiently the company converts operating cash flow to free cash.

Ilsung Pharm Competitors by Total Liabilities

The table below lists competitors of Ilsung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Nestcon Bhd KLSE:0235	Malaysia	RM635.15 Million
Winsome Resources Ltd AU:WR1	Australia	AU$18.66 Million
Hwashin Precision Engineering Co. Ltd KQ:126640	Korea	₩108.61 Billion
Arihant Capital Markets Limited NSE:ARIHANTCAP	India	Rs5.51 Billion
Seanergy Maritime Holdings Corp F:RHSR	Germany	€291.90 Million
COMMERCIAL SYN BAGS ORD (BSE) NSE:COMSYN	India	Rs1.53 Billion
Royce Global Value Trust Inc NYSE:RGT	USA	$432.94K
51 TALK ONL. SP.ADR A 60 F:C4G0	Germany	€88.67 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Ilsung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Ilsung Pharm.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	17.47	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ilsung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ilsung Pharm (2013–2025)

The table below shows the annual total liabilities of Ilsung Pharm from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩16.67 Billion ≈ $11.29 Million	+41.89%
2024-12-31	₩11.75 Billion ≈ $7.96 Million	-67.77%
2023-12-31	₩36.44 Billion ≈ $24.69 Million	-25.42%
2022-12-31	₩48.85 Billion ≈ $33.11 Million	+91.78%
2021-12-31	₩25.47 Billion ≈ $17.26 Million	+7.26%
2020-12-31	₩23.75 Billion ≈ $16.09 Million	-1.16%
2019-12-31	₩24.03 Billion ≈ $16.28 Million	+4.79%
2018-12-31	₩22.93 Billion ≈ $15.54 Million	-6.93%
2017-12-31	₩24.64 Billion ≈ $16.70 Million	+33.88%
2016-12-31	₩18.40 Billion ≈ $12.47 Million	-62.20%
2015-12-31	₩48.69 Billion ≈ $32.99 Million	-2.02%
2014-12-31	₩49.69 Billion ≈ $33.67 Million	-0.45%
2013-12-31	₩49.92 Billion ≈ $33.83 Million	--

About Ilsung Pharm

KO:003120 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$92.84 Million

₩137.00 Billion KRW

Market Cap Rank

#19401 Global

#934 in Korea

Share Price

₩20100.00

Change (1 day)

-1.23%

52-Week Range

₩18300.00 - ₩28300.00

All Time High

₩31693.76